Skip to main content
Jared Baeten, MD, Infectious Disease, Seattle, WA, UW Medicine/University of Washington Medical Center

JaredMurrayBaetenMD

Infectious Disease Seattle, WA

Associate Professor, Global Health and Community Medicine, University of Washington School of Medicine

Are you Dr. Baeten?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 74 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Jared Baeten, MD is an infectious disease specialist in Seattle, Washington. He is currently licensed to practice medicine in Washington and Massachusetts. He is affiliated with UW Medicine/Harborview Medical Center and UW Medicine/University of Washington Medical Center.

Education & Training

  • University of Washington
    University of WashingtonFellowship, Infectious Disease, 2006 - 2008
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 2003 - 2006
  • University of Washington School of Medicine
    University of Washington School of MedicineClass of 2003

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 2006 - 2025
  • MA State Medical License
    MA State Medical License 2005 - 2008
  • American Board of Internal Medicine Infectious Disease

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Gilead Presents Positive Proof-of-Concept Data for Investigational Combination Regimen of Lenacapavir with Broadly Neutralizing Antibodies as a Potential Twice-Yearly Approach for the Treatment of HIV
    Gilead Presents Positive Proof-of-Concept Data for Investigational Combination Regimen of Lenacapavir with Broadly Neutralizing Antibodies as a Potential Twice-Yearly Approach for the Treatment of HIVFebruary 22nd, 2023
  • Investigational Lenacapavir Receives Positive CHMP Opinion for People with Multi-Drug Resistant HIV
    Investigational Lenacapavir Receives Positive CHMP Opinion for People with Multi-Drug Resistant HIVJune 24th, 2022
  • New Clinical Data Support the Sustained Efficacy of Long-Acting Lenacapavir, Gilead’s Investigational HIV-1 Capsid Inhibitor
    New Clinical Data Support the Sustained Efficacy of Long-Acting Lenacapavir, Gilead’s Investigational HIV-1 Capsid InhibitorFebruary 16th, 2022
  • Join now to see all

Grant Support

  • PREP And Protective Immune Responses Against HIV-1National Institute Of Allergy And Infectious Diseases2012
  • Evaluation Of Antiretroviral HIV Prevention In African HIV Discordant CouplesNational Institute Of Nursing Research2011–2012
  • Optimizing Antiretroviral-Based HIV Prevention For HIV Serodiscordant CouplesNational Institute Of Mental Health2011
  • Contraception, PREGNANCY, And HIV-1 Risk In African HIV-1 Serodiscordant CouplesEunice Kennedy Shriver National Institute Of Child Health &Human Development2011

Professional Memberships

Hospital Affiliations